Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Nasopharyngeal Carcinoma 19Triple Negative Breast Neoplasms 11Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 8Advanced Solid Tumor 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Head and Neck Neoplasms 5Colorectal Neoplasms 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Transitional Cell 4Carcinoma, Renal Cell 4Solid Tumor 3Small Cell Lung Carcinoma 3Recurrence 3Rectal Neoplasms 3Turcot syndrome 2Sarcoma 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Neoplasms 2Microsatellite Stable Metastatic Colorectal Cancer 2Locally Advanced Rectal Cancer 2Liposarcoma 2Laryngeal Neoplasms 2Gestational Trophoblastic Disease 2Esophageal Neoplasms 2

Interventions

pembrolizumab 16Radiotherapy 15Paclitaxel 15Drug Therapy 14Cisplatin 13Carboplatin 10Radiation 9Immunotherapy 9Esophagectomy 9Fluorouracil 8Surgical Procedures, Operative 7Capecitabine 7Blood Specimen Collection 7Oxaliplatin 6Nivolumab 6Immune Checkpoint Inhibitors 6Chemoradiotherapy 6nimotuzumab 5Trastuzumab 5130-nm albumin-bound paclitaxel 5sintilimab 4camrelizumab 4Leucovorin 4trastuzumab deruxtecan 3tislelizumab 3patritumab deruxtecan 3Surveys and Questionnaires 3Endoscopy 3Bevacizumab 3toripalimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Esophageal Neoplasms × toripalimab × Clear all
NCT07177794 2026-04-21

EC-CRT-008

Sun Yat-sen University

Phase 3 Recruiting
242 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT06843889 2025-04-16

A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma

Nanfang Hospital, Southern Medical University

Phase 2 Recruiting
34 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡